Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.025 per share
-
Shares outstanding
-
61.5M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
29.6M
-
Shares change
-
-59.1K
-
Total reported value, excl. options
-
$352M
-
Value change
-
-$694K
-
Number of buys
-
13
-
Number of sells
-
-8
-
Price
-
$11.87
Significant Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) as of Q2 2023
34 filings reported holding GHRS - GH Research PLC - Ordinary shares, nominal value $0.025 per share as of Q2 2023.
GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.6M shares
of 61.5M outstanding shares and own 48.17% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.28M shares), RA CAPITAL MANAGEMENT, L.P. (5.59M shares), FMR LLC (4.13M shares), VR Adviser, LLC (3.52M shares), RTW INVESTMENTS, LP (2.17M shares), Lynx1 Capital Management LP (969K shares), Verition Fund Management LLC (796K shares), ORBIMED ADVISORS LLC (736K shares), Cormorant Asset Management, LP (593K shares), and Deep Track Capital, LP (499K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.